About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 401-420 of 454 trials

CompletedHsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyHsp90 inhibitor STA-9090 may stop the growth of tumor cells by blocking some of the proteins needed for cell growth.NCT01270880·Baltimore, Maryland and 3 others TerminatedA Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus…NCT05169684·Tucson, Arizona and 30 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingHigh-Risk Metachronous Oligometastatic Prostate Cancer TrialThe purpose of this research study is to compare the effects, good and/or bad, of using the standard of care treatment, hormonal therapy + Stereotactic Ablative Radiation (SABR)…NCT06212583·Baltimore, Maryland

Recruiting7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate CancerActivating the immune system to kill cancer cells is a promising therapeutic strategy for some patients with cancer.NCT06826924·Baltimore, Maryland

CompletedStudy of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)disulfiram is a DNA methyltransferase inhibitor that may provide benefit for patients with prostate cancer by restoring tumor suppressor genes.NCT01118741·Baltimore, Maryland and 2 others

CompletedCediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With DocetaxelThis randomized phase II trial is studying the side effects and how well giving cediranib maleate together with or without dasatinib works in treating patients with…NCT01260688·Peoria, Illinois and 7 others

CompletedPaclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerPhase II trial to study the effectiveness of combining paclitaxel and bryostatin 1 in treating patients who have metastatic prostate cancer that has not responded to hormone…NCT00005028·Baltimore, Maryland and 3 others

WithdrawnFocal Therapy for Prostate CancerProstate cancer is the most common solid organ cancer among men and is the second leading cause of cancer death.NCT01802307·Baltimore, Maryland

TerminatedTemsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerRATIONALE: Temsirolimus and vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01174199·Baltimore, Maryland and 1 other

CompletedA Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate CancerThe objective of the study is to determine if men with evidence of progressive prostate cancer while on chronic androgen ablation of ≥ 1 year duration will exhibit a clinical…NCT01084759·Baltimore, Maryland

Active not recruitingWater Vapor Ablation for Localized Intermediate Risk Prostate CancerThe purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2)…NCT05683691·Phoenix, Arizona and 24 others

CompletedEPO906 Therapy in Patients With Prostate CancerThis study will examine whether the new investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the…NCT00035113·Long Beach, California and 4 others

CompletedCOMbination of Bipolar Androgen Therapy and NivolumabSingle arm, multicenter, open-label Phase II study of the effects of parenteral testosterone in combination with nivolumab in men with metastatic castration-resistant prostate…NCT03554317·San Francisco, California and 2 others

CompletedStudy of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerThe purpose of this trial is to confirm a safe dose of AS1404, to be given with docetaxel, and to see whether adding AS1404 and docetaxel together improves the outcome of the…NCT00111618·Alhambra, California and 26 others

CompletedSafety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureThe purpose of this phase II, randomized, double-blind placebo controlled, multi-center study is to evaluate the safety and efficacy of 10 mg atrasentan in hormone naive subjects…NCT00038662·Homewood, Alabama and 39 others

CompletedObservational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerThis is a single-arm observational longitudinal study in of patients with metastatic castrate-resistant prostate cancer designed to assess the longitudinal trajectory of pain and…NCT02008058·Baltimore, Maryland and 3 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

Active not recruitingTowards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessFrailty is one of the main reasons older adults lose independence.NCT05968144·Baltimore, Maryland

CompletedA Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…NCT02952534·Birmingham, Alabama and 148 others

PreviousPage 21 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma